Varga; Zoltan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Varga; Zoltan.The latest application filed is for "linear drive".
Company Profile
1.22.28
- Varga; Zoltan - Miskolc HU
- VARGA; Zoltan - Kiskunfelegyhaza HU
- Varga; Zoltan - Budapest HU
- VARGA; Zoltan - Inarcs HU
- Varga; Zoltan - Gyermely HU
- Varga; Zoltan - Debrecen HU
- Varga; Zoltan - Victoria CA
- Varga; Zoltan - Lovohaz HU
- Varga; Zoltan - Kolesd HU
- Varga; Zoltan - Milwaukee WI
Patent Activity
| Patent | Date |
|---|---|
| Power base module Grant 11,407,097 - Czirjak , et al. August 9, 2 | 2022-08-09 |
| Linear Drive App 20220243792 - VARGA; Zoltan | 2022-08-04 |
| Process for the preparation of polymorph form B of treprostinil diethanolamine salt Grant 11,319,274 - Hortobagyi , et al. May 3, 2 | 2022-05-03 |
| Method For Determining The Lipid Content Of Extracellular Vesicles App 20210293834 - VISNOVITZ; Tamas ; et al. | 2021-09-23 |
| Tool Basic Module App 20210138617 - Czirjak; Peter ; et al. | 2021-05-13 |
| Method For The Production Of Lumateperone And Its Salts App 20210070755 - BERECZ; Gabor ; et al. | 2021-03-11 |
| Process For The Preparation Of Polymorph Form B Of Treprostinil Diethanolamine Salt App 20210053901 - HORTOB GYI; Iren ; et al. | 2021-02-25 |
| Power Base Module App 20190321960 - Czirjak; Peter ; et al. | 2019-10-24 |
| 4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity Grant 10,294,218 - Lori , et al. | 2019-05-21 |
| Multi-sized data types for managed code Grant 10,061,567 - de Icaza , et al. August 28, 2 | 2018-08-28 |
| Dasatinib salts Grant 10,023,566 - Marvanyos , et al. July 17, 2 | 2018-07-17 |
| Process for the preparation of vortioxetine salts Grant 9,822,086 - Ling , et al. November 21, 2 | 2017-11-21 |
| Novel 4,6-disubstituted Aminopyrimidine Derivatives Have Anti-hiv Activity App 20170204084 - Lori; Franco ; et al. | 2017-07-20 |
| Dasatinib Salts App 20170183334 - MARVANYOS; Ede Laszlo ; et al. | 2017-06-29 |
| Multi-sized Data Types For Managed Code App 20170131981 - de lcaza; Miguel ; et al. | 2017-05-11 |
| Process For The Preparation Of Vortioxetine Salts App 20170114034 - LING; Istvan ; et al. | 2017-04-27 |
| 4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity Grant 9,617,225 - Lori , et al. April 11, 2 | 2017-04-11 |
| Compounds for the treatment of ischemic injury Grant 9,457,046 - Ferdinandy , et al. October 4, 2 | 2016-10-04 |
| Multi-sized data types for managed code Grant 9,459,847 - de Icaza , et al. October 4, 2 | 2016-10-04 |
| Multi-sized Data Types For Managed Code App 20160132303 - de Icaza; Miguel ; et al. | 2016-05-12 |
| Managing Parameter Types For Generic Functions App 20160019037 - Varga; Zoltan | 2016-01-21 |
| 4-Pyrimidinylamino-benzenesulfonamide derivatives and their use for the inhibition of polo-like kinase 1 (PLK1) for the treatment of cancer and their use for the treatment of bacterial infections App 20150368209 - GREFF; Zoltan ; et al. | 2015-12-24 |
| Multi-sized data types for managed code Grant 9,183,020 - de Icaza , et al. November 10, 2 | 2015-11-10 |
| Modified peptide toxins Grant 9,062,119 - Varga , et al. June 23, 2 | 2015-06-23 |
| 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity Grant 9,040,529 - Greff , et al. May 26, 2 | 2015-05-26 |
| Modified Peptide Toxins App 20150087603 - Varga; Zoltan ; et al. | 2015-03-26 |
| Method for purifying diatomaceous earth Grant 8,883,860 - Mikulasik , et al. November 11, 2 | 2014-11-11 |
| Compounds For The Treatment Of Ischemic Injury App 20140256792 - Ferdinandy; Peter ; et al. | 2014-09-11 |
| Novel 4,6-disubstituted Aminopyrimidine Derivatives Having Both Aromatic And Halogenic Substituents App 20140057911 - Lori; Franco ; et al. | 2014-02-27 |
| Centralized route calculation for a multi-hop streetlight network Grant 8,570,190 - Marinakis , et al. October 29, 2 | 2013-10-29 |
| Method For Preparation Of An Excipient Suitable For Pharmaceutical Use App 20130225695 - Mikulasik; Endre ; et al. | 2013-08-29 |
| 4-phenylamino-pyrimidine Derivatives Having Protein Kinase Inhibitor Activity App 20120258968 - Greff; Zoltan ; et al. | 2012-10-11 |
| Method for preparing anisotropic particles and devices thereof Grant 8,263,029 - Jakli , et al. September 11, 2 | 2012-09-11 |
| Method For Preparing Anisotropic Particles And Devices Thereof App 20100158790 - Jakli; Antal ; et al. | 2010-06-24 |
| Polymorphs Of 5--6-chloro-1,3-dihydro-2h-indol-2-one Hydrobromide And Processes For Preparation Thereof App 20100081668 - Neu; Jozsef ; et al. | 2010-04-01 |
| Centralized route calculation for a multi-hop streetlight network App 20090066540 - Marinakis; Dimitri ; et al. | 2009-03-12 |
| Napthyridine Compounds As Rock Inhibitors App 20080207677 - Muller; Stefan ; et al. | 2008-08-28 |
| Pyrimidine Derivatives App 20080187575 - Klebl; Bert ; et al. | 2008-08-07 |
| Heterobicyclic Compounds as Pharmaceutically Active Agents App 20070275962 - Koul; Anil ; et al. | 2007-11-29 |
| Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins App 20060105445 - Godl; Klaus ; et al. | 2006-05-18 |
| Mass flow measuring device Grant 5,551,307 - Kane , et al. * September 3, 1 | 1996-09-03 |
| Balloon Balancing Toy Grant 3,870,298 - Varga March 11, 1 | 1975-03-11 |
Company Registrations
| SEC | 0001417418 | Varga Zoltan |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 